CDC WONDER MMWR

MMWR Query Table System

About These Tables

MMWR Morbidity Tables

Data for nationally notifiable diseases reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly in the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting.

Case counts in these query tables are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available.

Note that the list of diseases reported in each table, and the table format, vary by year and publication week.

Table I lists provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year). Table I shows the number of cases reported for the current week, the cumulative number of cases reported for the current year, the 5 year weekly average, and the total cases reported for each of the previous 5 years. Table I became available in 2007.

Table II lists cases of selected notifiable diseases by location within the United States, and shows the total cases for the current week, and the cumulative total number of cases in the previous 52 weeks.

Table III listed cases of selected notifiable vaccine-preventable diseases by publication week and location within the United States, In the past, table III included the following diseases: H. influenzae, invasive; Hepatitis A and B; Measles both indigenous and imported; Meningococcal disease; Mumps; Pertussis; Rubella. Table III for case reports of nationally notifiable diseases is available through year 2001. These conditions are currently reported in tables I (Mumps and Rubella) and II.

Table IV lists quarterly cases of Tuberculosis by location within the United States, and shows the total cases for the current quarter, and the minimum and maximum number of cases reported for the previous 4 quarters. In the past, AIDS and HIV/AIDS cases were included through year 2010. Table IV became available in year 2007.

The following conditions are included in the nationally notifiable diseases: †

Acquired Immune Deficiency Syndrome (AIDS) ⁴

Anthrax ¹

Arboviral diseases: California serogroup; Chikungunya virus; Eastern equine encephalitis virus; Jamestown Canyon virus; Powassan virus; St. Louis encephalitis virus; Western equine encephalitis virus ^{1 § ¶ *}

Babesiosis ²

Botulism: foodborne; infant; other (wound & unspecified) ¹

Brucellosis ¹

Campylobacteriosis ²

Chancroid ¹

Chlamydia trachomatis infection ²

Cholera ¹

Coccidioidomycosis ²

Cryptosporidiosis ²

Cyclosporiasis ^{1 §}

Dengue Virus Infection: Dengue Fever; Severe Dengue ^{¶ 2}

Diphtheria ¹

Ehrlichiosis/Anaplasmosis: Ehrlichia chaffeensis; Anaplasma phagocytophilum; Undetermined ²

Giardiasis ²

Gonorrhea ²

Haemophilus influenzae, invasive, all ages, all serotypes ²

Haemophilus influenzae, invasive disease (age <5 yrs): serotype b; not typable serotype; other serotype; unknown serotype ¹

Hansen's disease ^{§ 1}

Hantavirus Infections: Hantavirus infection (non-HPS); Hantavirus pulmonary syndrome (HPS) ^{§ ¶ 1}

Hemolytic uremic syndrome, post-diarrheal ^{§ 1}

Hepatitis (viral, acute): type A; type B; type C ²

Hepatitis B, virus infection perinatal ¹

HIV/AIDS ⁴

HIV infection, pediatric (age <13 yrs) ⁴

Influenza-associated pediatric mortality ^{§ 1}

Invasive Pneumococcal Disease: all ages; age <5 years ^{* 2}

Legionellosis ²

Leptospirosis ^{§ 1}

Listeriosis ¹

Lyme disease ²

Malaria ²

Measles ¹

Meningococcal disease, invasive: A, C, Y, and W-135; serogroup B; other serogroup; unknown serogroup ¹

Meningococcal diseases, invasive, All serogroups ²

Mumps ²

Novel influenza A infection virus ¹

Pertussis ²

Plague ¹

Poliomyelitis, paralytic ¹

Poliovirus infection, nonparalytic ^{§ 1}

Psittacosis ^{§ 1}

Q fever: acute; chronic ^{§ 1}

Rabies: human ¹

Rabies: animal ²

Rocky Mountain spotted fever ²

Rubella ²

Rubella, congenital syndrome ²

Salmonellosis ²

SARS CoV ^{§ 1}

Shiga toxin-producing E. coli(STEC): includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; Shiga toxin-positive, not serogrouped ²

Shigellosis ²

Smallpox ^{§ 1}

Spotted Fever Rickettsiosis (including Rocky Mountain spotted Fever (RMSF)): confirmed; probable ^{* 2}

Streptococcal disease, invasive, group A ²

Streptococcus pneumoniae, invasive disease, age <5 years ²

Streptococcus pneumoniae, invasive disease, drug resistant ²

Streptococcal toxic-shock syndrome ^{§ 1}

Syphilis, congenital (age <1 yr) ^{§ 1}

Syphilis, primary & secondary ²

Tetanus ²

Toxic-shock syndrome (staphylococcal) ^{§ 1}

Trichinellosis ^{§ 1}

Tuberculosis ⁴

Tularemia ¹

Typhoid fever ¹

Vancomycin-intermediate Staphylococcus aureus ^{§ 1}

Vancomycin-resistant Staphylococcus aureus ^{§ 1}

Varicella (chickenpox) ²

Vibriosis (any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139) ²

Viral hemorrhagic Fevers: Crimean-Congo hemorrhagic fever; Ebola hemorrhagic fever; Guanarito hemorrhagic fever; Junin hemorrhagic fever; Lassa fever; Lujo virus; Machupo hemorrhagic fever; Marburg fever; Sabia-associated hemorrhagic fever ^{§ 1}

West Nile virus disease: Neuroinvasive; Non-neuroinvasive ^{§ 2}

Yellow fever ¹

Notes:

† For all conditions: Case counts are provisional and subject to change. Please refer to the footnotes below the tables for more information. Refer to the MMWR publication for weekly updates to the footnotes for various conditions. Note that the list of diseases reported in each table, and the table format, vary by year and publication week. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.

§ Not reportable in all states. Data from states where the condition is not reportable are excluded, except starting in 2007 for the Arboviral diseases, STD data, TB data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/document/SRCA_FINAL_REPORT_2006-2012_final.xlsx.

¶ Pending approval: Data for the Arboviral disease, Chikungunya, Hantavirus infection disease, non-Hantavirus Pulmonary Syndrome (HPS), and Dengue-like illness will be displayed after the CDC obtains Office of Management and Budget Paperwork Reduction Act approval to receive data for these conditions.

* Other reporting issues:

For Arboviral diseases: California serogroup available for years 2007-2015; Jamestown Canyon virus data begins in 2016; La Crosse virus data begins in 2016.
For Invasive Pneumococcal disease: this condition includes drug resistant and susceptible cases of Invasive Pneumococcal Disease; this condition was previously named Streptococcus pneumoniae invasive disease and cases were reported to CDC using different event codes to specify whether the cases were drug resistant or in a defined age group, such as <5 years.
For Spotted Fever Rickettsiosis: Illnesses with similar clinical presentation that result from Spotted Fever Group Rickettsia infections are reported as Spotted Fever Rickettsioses. Rocky Mountain Spotted Fever (RMSF), caused by Rickettsia rickettsii, is the most common and well-known Spotted Fever.

1 Infrequently reported conditions are listed in table I. Conditions listed are current as of January 14, 2016.

2 Conditions reported in table II. Conditions listed are current as of January 14, 2016.

3 Selected vaccine preventable diseases were reported in table III through 2001: H. influenzae, invasive; Hepatitis (viral): type A, type B; Measles (Rubeola): Indigenous, Imported, Total; Meningococcal Disease; Mumps; Pertussis; Rubella.

4 Conditions reported quarterly in table IV: Tuberculosis, by quarter, with cumulative totals for the year and prior year. AIDS, HIV/AIDS and Tuberculosis reports are available for years 2007 - 2010. Conditions listed are current as of January 14, 2016. See National Notifiable Diseases Surveillance System (NNDSS) for more information.

122 Cities Mortality Tables

As part of its national influenza surveillance effort, CDC receives weekly mortality reports from 122 cities and metropolitan areas in the United States within 2-3 weeks from the date of death. These reports summarize the total number of deaths occurring in these cities/areas each week, as well as the number due to pneumonia and influenza. Data are published weekly in the Morbidity and Mortality Weekly Report (MMWR).